GlobeNewswire 3/26/2020 Kuros Biosciences Reports Results for the Full Year 2019
GlobeNewswire 3/18/2020 Kuros Strengthens Orthobiologics Patent Portfolio
GlobeNewswire 2/3/2020 Affimed Mourns Passing of Chief Financial Officer Dr. Florian Fischer
GlobeNewswire 1/30/2020 Kuros Reports Publication of MagnetOs Preclinical Data Demonstrating Superiority to Market-Leading S...
GlobeNewswire 10/2/2019 Kuros Biosciences to Host Key Opinion Leader Meeting in Zurich Showcasing its Commercial Stage Advan...
GlobeNewswire 9/24/2019 Kuros Biosciences announces full commercial launch of MagnetOs™ and exhibitor status at North Americ...
GlobeNewswire 9/3/2019 Kuros Biosciences Announces U.S. FDA approval of IND Application to Initiate Fibrin-PTH Phase 2a Cli...
GlobeNewswire 8/20/2019 Kuros Biosciences Reports Results for First Half 2019
GlobeNewswire 7/9/2019 Kuros Biosciences Signs Agreement with Surgical Specialties on Distribution of MagnetOs in Australia...
GlobeNewswire 4/30/2019 Kuros Biosciences to Propose Re-Appointment of Chairman and Board Members at Annual General Meeting
GlobeNewswire 4/12/2019 Kuros Biosciences Reports Results for the Full Year 2018
GlobeNewswire 4/9/2019 Kuros Biosciences Enters Convertible Bond Financing Agreement For Up To CHF 5 Million
GlobeNewswire 3/13/2019 Kuros Biosciences Receives US Marketing Clearance for Intervertebral Body Fusion Device
GlobeNewswire 2/11/2019 Kuros Biosciences Signs Agreement to Supply SeaSpine with Bone Graft Incorporating Kuros’s Advanced ...
GlobeNewswire 12/17/2018 Kuros Ends Transformational Year With First MagnetOs Sales, Lead Clinical Program on Track, and Succ...
GlobeNewswire 12/13/2018 Kuros Announces Final Result of Capital Increase – Total Gross Proceeds of 16.1 Million Raised
GlobeNewswire 12/12/2018 Kuros Announces Results of Rights Offering – Capital Increase Will be Implemented
GlobeNewswire 12/10/2018 Kuros Receives FDA 510(k) Clearance for Extending Commercial Indications of MagnetOs Putty in the Un...
GlobeNewswire 12/6/2018 Kuros Reports Publication of MagnetOs Data Demonstrating Equivalence to Autologous Bone in Spinal Fu...
GlobeNewswire 9/25/2018 Kuros Biosciences Appoints Strategic Advisory Board
GlobeNewswire 9/13/2018 Kuros Biosciences to Host Key Opinion Leader Meeting on Establishing the New Gold Standard in Bone R...
GlobeNewswire 9/5/2018 Kuros Biosciences Reports Results for First Half 2018
GlobeNewswire 8/23/2018 Kuros Biosciences Appoints Pascal Longlade as Chief Medical Officer
GlobeNewswire 7/2/2018 Kuros Biosciences Reports First U.S. & UK sales of MagnetOs
GlobeNewswire 6/19/2018 Kuros Biosciences to Present Promising Clinical Case Studies with MagnetOs at Leading Spine Surgery ...